ProQR Therapeutics (PRQR) Other financing activities (2018 - 2019)
ProQR Therapeutics' (PRQR) quarterly Other financing activities came in at -$12.2 million in Q2 2019, down 88.09% year-on-year from -$102.1 million in Q2 2018, and down 88.09% quarter-over-quarter from -$6.5 million in Q2 2018.
ProQR Therapeutics (PRQR) Other financing activities (2018 - 2019) Analysis & Trends
ProQR Therapeutics has disclosed Other financing activities across 2 years of filings, most recently posting -$12.2 million for Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | ProQR Therapeutics | 7.27 Mn | -100.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -12.16 Mn |
| Jun 30, 2019 | -12.16 Mn |
| Jun 30, 2018 | -6.46 Mn |
| Jun 30, 2018 | -6.46 Mn |